Surgery Partners, Inc.

SGRY Healthcare Medical Care Facilities

Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024. In the quarter to June 2026, revenue grew 2.75%, EPS fell 500.0%, free cash flow fell 60.6% and total debt rose 4.92%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.

14.64 0.13 −0.88%
Market cap
$1.9B
P/E
0.0×
Fwd P/E
−94.9×
Dividend yield
—
F-score
4/9
Altman Z
0.75
Beneish M
−2.52
Dividend safety
4/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.84 0.59 0.46 0.64
P/FCF ratio
11.56 8.12 6.13 11.30
P/Operating CF
32.93 19.01 130.78 36.50
P/B ratio
0.88 0.63 0.49 0.70
EV/Sales
1.86 1.64 1.51 1.69
EV/EBITDA
10.54 9.22 8.54 9.77
EV/FCF
25.67 22.42 20.27 29.76
Current Ratio
1.88 1.87 1.86 1.95
Net Debt/EBITDA
22.34 19.59 32.58 23.91
Debt/Equity
1.13 1.18 1.20 1.21
Earnings Yield
(6.28%) (4.01%) (5.03%) (4.17%)
Free Cash Flow Yield
8.65% 12.32% 16.32% 8.85%
Free Cash Flow per Share
0.50 0.74 (0.03) 0.29
Book value per Share
24.70 24.62 24.13 24.08
Free Cash Flow
63.80 94.20 (4.30) 37.80
EV/EBIT
14.22 13.16 12.20 14.03
Other line items

Show all line items

Columns are period end dates